A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
ConditionUlcerative Colitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorBristol-Myers Squibb
About this trial
The purpose of this study is to evaluate association between ozanimod exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.
Eligibility criteria
Qualifiers
Currently or recently pregnant
Diagnosis of UC
Resident of country where ozanimod is prescribed for the treatment of UC
Disqualifiers
Exposure to other S1P therapies at any time during pregnancy
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,182 Participants
are grouped into 3 trial groupsLocations
1PPD Virtual - PPD - US28401-3331, WilmingtonNorth Carolina, United States
Sponsors and collaborators
Bristol-Myers Squibb
Lead sponsor
Source ClinicalTrials.gov